MYLAN 711 (Hydrochlorothiazide and methyldopa 25 mg / 250 mg)

Pill imprint MYLAN 711 has been identified as Hydrochlorothiazide and methyldopa 25 mg / 250 mg.

Hydrochlorothiazide/methyldopa is used in the treatment of high blood pressure and belongs to the drug class antiadrenergic agents (central) with thiazides. Risk cannot be ruled out during pregnancy. Hydrochlorothiazide/methyldopa 25 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Hydrochlorothiazide and methyldopa

Imprint:

MYLAN 711

Strength:

25 mg / 250 mg

Color:

Green

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Antiadrenergic agents (central) with thiazides

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-0711

Inactive Ingredients:

silicon dioxide
croscarmellose sodium
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Yellow No. 6
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
triacetin

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
49999-0082	Lake Erie Medical and Surgical Supply (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.